O’Brien, Cecelia M. http://orcid.org/0000-0001-5299-7197
Louise, Jennie
Deussen, Andrea
Dodd, Jodie M.
Funding for this research was provided by:
National Health and Medical Research Council (519240, 627005)
RANZCOG Research Foundation (Luke Proposch Scholarship)
Article History
Received: 15 May 2019
Accepted: 7 August 2019
First Online: 10 October 2019
Ethics approval and consent to participate
: Women were recruited from 3 public hospitals across metropolitan Adelaide and provided written informed consent to participate. The ethics approval study number for LIMIT randomised controlled trial was 1839/6 (approved July 2006) and for the fetal growth ancillary study number was 2051/4 (approved April 2008).Each collaborating site obtained their individual ethics approval for the LIMIT randomised controlled trial including The Women’s and Children’s Health Network (WCHN) Human Research Ethics Committee’s (application REC 1839/6/2012); Ethics of Human Research Committee, The Queen Elizabeth Hospital and Lyell McEwin Hospital (application 2,008,033); and Flinders Clinical Research Ethics Committee, Flinders Medical Centre (Application 128/08). The fetal growth ancillary study was approved in April 2008 by the The Women’s and Children’s Health Network (WCHN) Human Research Ethics Committee’s (HREC) (application 2051/4).
: Not applicable.
: The authors declare that they have no competing interests.